Exploiting the Interplay between Innate and Adaptive Immunity to Improve Immunotherapeutic Strategies for Epstein-Barr-Virus-Driven Disorders

<table>Interplay between EBV and innate immunity effectors. Main activating (dark lines) and inhibitory (red lines) effects of EBV infection on B lymphocytes (B), neutrophils (N), macrophages (MA), monocytes (MO), epithelial (E), dendritic (DC), and natural killer (NK) cells. Potential sites of intervention of targeted therapy approaches are also suggested (arrows). For further insights see text.</table>

Journal of Immunology Research

fig1

Figure 1

Figure 1: Exploiting the Interplay between Innate and Adaptive Immunity to Improve Immunotherapeutic Strategies for Epstein-Barr-Virus-Driven Disorders 

Figure 1 | Exploiting the Interplay between Innate and Adaptive Immunity to Improve Immunotherapeutic Strategies for Epstein-Barr-Virus-Driven Disorders 